title: Measuring the effects of therapy in Parkinson disease.
authors.forename: Clifford W
authors.initials: CW
authors.lastname: Shults
authors.forename: Richard
authors.initials: R
authors.lastname: Haas
authors.forename: David
authors.initials: D
authors.lastname: Oakes
authors.forename: Karl
authors.initials: K
authors.lastname: Kieburtz
authors.forename: Sandra
authors.initials: S
authors.lastname: Plumb
authors.forename: Ira
authors.initials: I
authors.lastname: Shoulson
authors.forename: M Flint
authors.initials: MF
authors.lastname: Beal
authors.forename: Jorge
authors.initials: J
authors.lastname: Juncos
authors.forename: John
authors.initials: J
authors.lastname: Nutt
mesh_terms: D000975:Antioxidants / Q000627:therapeutic use*; D000978:Antiparkinson Agents / Q000627:therapeutic use*; D003067:Coenzymes; D006801:Humans; D009460:Neurologic Examination; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy*; D014451:Ubiquinone / Q000031:analogs & derivatives* / Q000627:therapeutic use*
chemical_list: D000975:Antioxidants; D000978:Antiparkinson Agents; D003067:Coenzymes; D018696:Neuroprotective Agents; D014451:Ubiquinone; C024989:coenzyme Q10